These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3895987)

  • 21. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
    Mavissakalian M; Perel JM
    Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone.
    Pohl R; Balon R; Yeragani VK; Gershon S
    Psychopathology; 1989; 22 Suppl 1():60-7. PubMed ID: 2657839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M; Perel JM; Michelson L
    J Clin Psychopharmacol; 1984 Feb; 4(1):36-40. PubMed ID: 6693582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of panic disorder to fixed doses of alprazolam or imipramine.
    Uhlenhuth EH; Matuzas W; Glass RM; Easton C
    J Affect Disord; 1989; 17(3):261-70. PubMed ID: 2529295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia.
    Mavissakalian M
    J Clin Psychiatry; 1990 May; 51(5):184-8. PubMed ID: 2335493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autonomic changes after treatment of agoraphobia with panic attacks.
    Roth WT; Telch MJ; Taylor CB; Agras WS
    Psychiatry Res; 1988 Apr; 24(1):95-107. PubMed ID: 3393620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.
    Mavissakalian M; Michelson L; Dealy RS
    Br J Psychiatry; 1983 Oct; 143():348-55. PubMed ID: 6626853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.
    Lepola UM; Rimón RH; Riekkinen PJ
    Int Clin Psychopharmacol; 1993; 8(2):115-8. PubMed ID: 8345160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-year follow-up of exposure and imipramine treatment of agoraphobia.
    Mavissakalian M; Michelson L
    Am J Psychiatry; 1986 Sep; 143(9):1106-12. PubMed ID: 3529993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC; Garcia-Sevilla JA; Cameron OG; Smith CB
    Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996
    [No Abstract]   [Full Text] [Related]  

  • 33. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
    Pohl R; Berchou R; Rainey JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R; Anderson DJ; Clancy J; Crowe RR; Slymen DJ; Ghoneim MM; Hinrichs JV
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific side effects of long-term imipramine management of panic disorder.
    Mavissakalian M; Perel J; Guo S
    J Clin Psychopharmacol; 2002 Apr; 22(2):155-61. PubMed ID: 11910260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clomipramine treatment of agoraphobic women. An eight-week controlled trial.
    Johnston DG; Troyer IE; Whitsett SF
    Arch Gen Psychiatry; 1988 May; 45(5):453-9. PubMed ID: 3282481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance drug therapy of panic disorder.
    Curtis GC; Massana J; Udina C; Ayuso JL; Cassano GB; Perugi G
    J Psychiatr Res; 1993; 27 Suppl 1():127-42. PubMed ID: 8145175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.